Logo Medical Science Monitor

Call: +1.631.470.9640
Closed: National Holiday

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

20 May 2010

Technical aspects and short-term results of primary coiling of giant intracranial aneurysms: A 12-year, single-center experience

Zbigniew Serafin, Piotr Strześniewski, Maciej Osmański, Władysław Lasek, Wojciech Beuth

Med Sci Monit 2010; 16(1): 33-39 :: ID: 880580

Abstract

Background: To retrospectively evaluate the clinical and angiographic outcome in patients with giant intracranial aneurysms, who had been primarily treated with detachable coils.
Material/Methods: A group of 23 patients with saccular intracranial giant aneurysms, who were treated with endovascular embolization, was analyzed. Evaluation included clinical presentation, technical success rate, complications, early clinical outcome, and results of early (6 months) angiographic follow-up.
Results: Embolization was feasible in all cases. Immediate total occlusion of the aneurysm was achieved in 9 patients, subtotal in 7, and incomplete in 7. Among the 23 treated patients, 9 showed improvement of clinical symptoms, 8 remained stable, 4 worsened, and 2 died. No rebleeding was noted either during the hospitalization period or after discharge. After 6 months, recanalization of a different grade was noted in 10 patients, and in 6 patients additional embolization was necessary. Recanalization was more common with the use of two-dimensional coils only (57%) than with the use of two-dimensional and three-dimensional coils (50%) or with stent assistance (0%).
Conclusions: Despite the low periprocedural risk for the patient, embolization with detachable coils only is not encouraging owing to frequent recanalization, and may be considered as an alternative to surgery only in carefully selected patients, and with stent assistance.

Keywords: giant intracranial aneurysm, transarterial embolization, Guglielmi detachable coil, intracranial stent, intracranial aneurysm

Add Comment 0 Comments

Editorial

01 May 2024 : Editorial  

Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)

Dinah V. Parums

DOI: 10.12659/MSM.944927

Med Sci Monit 2024; 30:e944927

In Press

Clinical Research  

Percutaneous Coronary Intervention as a Non-Surgical Treatment for Ischemic Mitral Regurgitation in Patient...

Med Sci Monit In Press; DOI: 10.12659/MSM.943122  

Clinical Research  

Maxillary Canine Impaction: Assessing the Influence of Maxillary Anatomy Using Cone Beam Computed Tomography

Med Sci Monit In Press; DOI: 10.12659/MSM.944306  

Clinical Research  

Optimal Duration of Cold and Heat Compression for Forearm Muscle Biomechanics in Mixed Martial Arts Athlete...

Med Sci Monit In Press; DOI: 10.12659/MSM.944149  

Clinical Research  

A Retrospective Study of the Presentation, Diagnosis, Management, and Outcomes of 27 Patients with Osteogen...

Med Sci Monit In Press; DOI: 10.12659/MSM.944364  

Most Viewed Current Articles

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750